1 year return (CAGR)
112.00%
Acumen Pharmaceuticals Inc Exchange (NASDAQ, USD)
ABOS
2.65
+0.08 (+3.11%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-21.68%
5 year return (CAGR)
-31.05%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
191.64M
Price/Sales
-
Ent value
190.94M
Price/Book
3.35
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
50.94%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.55 |
| Daily high | 2.67 |
| Daily low | 2.52 |
| Daily Volume | 890K |
| All-time high | 20.28 |
| 1y analyst estimate | 7.40 |
| Beta | 0.33 |
| EPS (TTM) | -1.45 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 30 Mar 2026 |
Downside potential
Loading...
Downside potential data
| ABOS | S&P500 | |
| Current price drop from All-time high | -86.93% | -2.08% |
| Highest price drop | -95.56% | -56.47% |
| Date of highest drop | 17 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -77.76% | -10.68% |
| Avg time to new high | 655 days | 12 days |
| Max time to new high | 1309 days | 1805 days |
News
